GreenLight Biosciences Q3 EPS $(0.27), Sales $1.73M

GreenLight Biosciences (NASDAQ:GRNA) reported quarterly losses of $(0.27) per share. The company reported $1.73 million in sales this quarter.

GreenLight Biosciences (NASDAQ:GRNA) reported quarterly losses of $(0.27) per share. The company reported $1.73 million in sales this quarter.

Total
0
Shares
Related Posts
Read More

AT&T CEO John Stankey Updates Shareholders At The 2023 UBS Global Media & Communications Conference; Says On Track For 2023 Full-Year Free Cash Flow Of About $16.5B; Expects 2024 Capital Investment In The $21B-22B Range

As part of AT&T's multiyear strategy to drive sustainable and profitable growth, the company detailed how it will accelerate network innovation, efficiency and structural cost improvement across the largest wireless

T